Keith Wayne Ward's Net Worth
$6.85 Million
Who is Keith Wayne Ward?
Keith Wayne Ward has an estimated net worth of $6.85 Million. This is based on reported shares across multiple companies, which include REATA PHARMACEUTICALS INC, and Skye Bioscience, Inc..
SEC CIK
Keith Wayne Ward's CIK is 0001662394
Past Insider Trading and Trends
2019 was Keith Wayne Ward's most active year for acquiring shares with 12 total transactions. Keith Wayne Ward's most active month to acquire stocks was the month of December. 2019 was Keith Wayne Ward's most active year for disposing of shares, totalling 18 transactions. Keith Wayne Ward's most active month to dispose stocks was the month of December. 2018 saw Keith Wayne Ward paying a total of $662,340.00 for 114,000 shares, this is the most they've acquired in one year. In 2019 Keith Wayne Ward cashed out on 163,241 shares for a total of $4,220,931.55, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
REATA PHARMACEUTICALS INC No price found
Chief Development Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$91.13 | -$3,678,584.54 | 8.62K |
Scheduled
|
Feb 25 - Feb 26
| ||
Form 4
|
—
|
0
|
$76.70 | -$318,302.11 | 8.62K |
Scheduled
|
Jan 31
| ||
Form 4
|
∞
| 8.62K |
—
|
—
| 8.62K |
Jan 14
| |||
Form 4
|
—
|
0
|
$53.99 | -$224,044.90 |
0
|
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
$66.97 | -$318,108.97 |
0
|
Scheduled
|
Nov 7
| ||
Form 4
|
—
|
0
|
$59.48 | -$282,530.00 |
0
|
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$57.08 | -$813,390.00 |
0
|
Scheduled
|
Oct 23
| ||
Form 4
|
—
|
0
|
$36.62 | -$173,945.00 |
0
|
Scheduled
|
Jul 5
| ||
Form 4
|
—
|
0
|
$36.62 | -$1,043,670.00 |
0
|
Scheduled
|
Jun 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Skye Bioscience, Inc. (SKYE) Snapshot price: $5.84
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||